These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18565374)

  • 21. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    Pediatr Dent; 2008; 30(3):220-4. PubMed ID: 18615987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    J Endod; 2008 Jul; 34(7 Suppl):S25-8. PubMed ID: 18565368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histology of Irreversible pulpitis premolars treated with mineral trioxide aggregate pulpotomy.
    Chueh LH; Chiang CP
    Oper Dent; 2010; 35(3):370-4. PubMed ID: 20533639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis).
    El-Meligy OA; Avery DR
    Pediatr Dent; 2006; 28(5):399-404. PubMed ID: 17036703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulp therapy in primary teeth--profile of teaching in Brazilian dental schools.
    Bergoli AD; Primosch RE; de Araujo FB; Ardenghi TM; Casagrande L
    J Clin Pediatr Dent; 2010; 35(2):191-5. PubMed ID: 21417123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts in vital pulpotomies in primary teeth.
    Castro A
    J Mich Dent Assoc; 2005 Jan; 87(1):26-8. PubMed ID: 15714830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.
    Barrieshi-Nusair KM; Qudeimat MA
    J Endod; 2006 Aug; 32(8):731-5. PubMed ID: 16861071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential toxicity.
    Duggal MS; Curzon ME; Balmer R; Roberts J
    Br Dent J; 2005 May; 198(9):563; author reply 563. PubMed ID: 15895056
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical applications of mineral trioxide aggregate.
    Torabinejad M
    Alpha Omegan; 2004 Dec; 97(4):23-31. PubMed ID: 15651581
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE.
    Ghoddusi J; Shahrami F; Alizadeh M; Kianoush K; Forghani M
    N Y State Dent J; 2012 Apr; 78(3):34-8. PubMed ID: 22803275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mineral trioxide aggregate pulpotomy of a primary second molar in a patient with agenesis of the permanent successor.
    Moretti AB; Oliveira TM; Sakai VT; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2007 Sep; 40(9):738-45. PubMed ID: 17608676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case series: management of immature permanent teeth with pulpal necrosis: a case series.
    McTigue DJ; Subramanian K; Kumar A
    Pediatr Dent; 2013; 35(1):55-60. PubMed ID: 23635900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of indirect pulp capping using three different materials: A randomized control trial using cone-beam computed tomography.
    Mathur VP; Dhillon JK; Logani A; Kalra G
    Indian J Dent Res; 2016; 27(6):623-629. PubMed ID: 28169260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial.
    Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I
    J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scanning electron microscopy evaluation of the hard tissue barrier after pulp capping with calcium hydroxide, mineral trioxide aggregate (MTA) or ProRoot MTA.
    Reston EG; de Souza Costa CA
    Aust Endod J; 2009 Aug; 35(2):78-84. PubMed ID: 19703080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there life after Buckley's Formocresol? Part I -- a narrative review of alternative interventions and materials.
    Srinivasan V; Patchett CL; Waterhouse PJ
    Int J Paediatr Dent; 2006 Mar; 16(2):117-27. PubMed ID: 16430526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do we still need formocresol in pediatric dentistry?
    Casas MJ; Kenny DJ; Judd PL; Johnston DH
    J Can Dent Assoc; 2005 Nov; 71(10):749-51. PubMed ID: 16324226
    [No Abstract]   [Full Text] [Related]  

  • 40. Knowledge and practice of, and attitudes toward, pulp therapy in deciduous teeth among pediatric dentists in India.
    Nayak UA; Wadhwa S; Kashyap N; Prajapati D; Mahuli AV; Sharma R
    J Investig Clin Dent; 2018 Feb; 9(1):. PubMed ID: 28762655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.